Effect of Platelet-Rich Plasma, Platelet-Poor Plasma, & Bone Marrow Aspirate Concentrate Application on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies: A Prospective Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Biological
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age: \> or equal to 18 years

• Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology

• Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \& sign the informed consent document

Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Scott D. Martin, MD
sdmartin@mgh.harvard.edu
617-732-5329
Time Frame
Start Date: 2023-08-30
Estimated Completion Date: 2045-08-30
Participants
Target number of participants: 160
Treatments
Experimental: Bone marrow aspirate concentrate (BMAC)
Patients randomly allocated to receive BMAC will undergo hip arthroscopy and will receive PRP/PPP/BMAC application through the PI's standardized method of harvest, processing, and application.
Placebo_comparator: Control
Patients allocated to the control cohort will receive standard of care hip arthroscopy without PRP/PPP/BMAC application.
Related Therapeutic Areas
Sponsors
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov